| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.47B | -7.3% |
| Cost of Revenue | $7.10B | -5.7% |
| R&D Expense | $42.0M | -6.7% |
| SG&A Expense | $1.38B | -13.7% |
| Operating Income | $2.60B | -8.0% |
| Interest Expense | $753.2M | -13.6% |
| Pre-tax Income | $2.31B | -3.6% |
| Income Tax | $565.1M | -3.4% |
| Net Income | $1.74B | -3.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $373.6M | -39.9% |
| Short-term Investments | $397K | -99.9% |
| Accounts Receivable | $619.6M | -6.2% |
| Inventory | $267.8M | -12.9% |
| Current Assets | $1.85B | -9.7% |
| Total Assets | $11.13B | -1.0% |
| Current Liabilities | $4.78B | +5.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.53B | -2.4% |
| Capital Expenditures | $132.6M | +8.3% |
| Investing Cash Flow | -$266.7M | -16.4% |
| Financing Cash Flow | -$1.51B | +27.8% |
| Free Cash Flow | $1.40B | -3.4% |
| Long-term Debt |
| $9.76B |
| -17.1% |
| Total Liabilities | $15.08B | -11.0% |
| Stockholders' Equity | -$3.95B | +30.8% |